A carregar...

Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement

Background. Adalimumab (ADA) is effective for patients with Crohn’s disease (CD). However, there have been few reports on ADA therapy with respect to its relationship with pathologic findings and drug efficacy in biologically naïve CD cases. Methods. Fifteen patients with active biologically naïve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsutomu Mizoshita, Satoshi Tanida, Hironobu Tsukamoto, Keiji Ozeki, Takahito Katano, Hirotaka Nishiwaki, Masahide Ebi, Yoshinori Mori, Eiji Kubota, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Limited 2014-01-01
Colecção:Gastroenterology Research and Practice
Acesso em linha:http://dx.doi.org/10.1155/2014/687257
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!